


Apex Labs Revenue
Pharmaceutical Manufacturing • Vancouver, British Columbia, Canada • 11-20 Employees
Apex Labs revenue & valuation
| Annual revenue | $1,368,880 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Pharmaceutical Manufacturing industry and current estimated revenues | $4,400,000 |
| Total funding | $4,000,000 |
Key Contacts at Apex Labs
Tyler Powell
Chief Executive Officer
Tom Mcgaugh
Independent Director
Company overview
| Headquarters | 1040 W Georgia St, Suite 1050, Vancouver, British Columbia V6E 4H1, CA |
| Phone number | +18883313244 |
| Website | |
| NAICS | 3254 |
| Keywords | Clinical Trials, Depression, Capital Markets, Finance, Research And Development, Pharmaceuticals, Laboratory, Veterans, Psychotherapy, Drug Development, Ptsd, First Responders, Public Markets, Ketamine, Psychedelics, DMT, Mental Disorders, LSD, Psilocybin, Mdma, Psilocin, Dealer'S Licence, Neo Exchange, Section 56(1) Exemptions |
| Founded | 2018 |
| Employees | 11-20 |
| Socials |
Apex Labs Email Formats
Apex Labs uses 2 email formats. The most common is {first initial} (e.g., j@apexlabs.com), used 71.4% of the time.
| Format | Example | Percentage |
|---|---|---|
{first initial} | j@apexlabs.com | 71.4% |
{first name} | john@apexlabs.com | 28.6% |
About Apex Labs
APEX is a patient-driven pharmaceutical company focused on optimizing the standard of mental health care with psilocybin by bringing data supported, clinically evaluated drugs to market for depression and anxiety in PTSD. Our strategy is focused on developing pharmaceutical products through a phased clinical program evaluating safety and efficacy across multiple indications, alongside a robust early access program. APEX has two GMP Certified drug assets. APEX-52 is microdose synthetic psilocybin for clinical evaluation, currently in active phase 2b trials, and APEX-25 is the company’s macro dose drug asset, developed for in-clinic dosing with assisted psychotherapy. APEX recently launched North America’s first take-home psilocybin trial, and received approval for the world’s largest psilocybin clinical trial to-date both evaluating APEX-52 in the treatment of anxiety and depression in diagnosed PTSD. APEX is driven by an experienced and passionate leadership team from the Veteran community, healthcare, drug policy and emerging sectors who want to make a difference and disrupt the $380+ billion global mental health market. Find out more at apexlabs.com
Employees by Management Level
Total employees: 11-20
Seniority
Employees
Employees by Department
Apex Labs has 14 employees across 6 departments.
Departments
Number of employees
Apex Labs Tech Stack
Discover the technologies and tools that power Apex Labs's digital infrastructure, from frameworks to analytics platforms.
Security
JavaScript libraries
Font scripts
JavaScript libraries
Programming languages
Blogs
JavaScript graphics
Analytics
UI frameworks
SEO
Tag managers
Reverse proxies
Frequently asked questions
4.8
40,000 users



